NASDAQ : SHC
Sotera Health Company — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 18.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.13B |
| Enterprise Value | 7.04B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 285.37M |
| Shares Outstanding | 285.37M |
| Shares Change (YoY) | +1.36% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 2.19% |
| Owned by Institutions (%) | 70.59% |
| Float | 200.85M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 31.68 |
| Forward PE | 17.51 |
| PS Ratio | 4.24 |
| Forward PS | 4.02 |
| PB Ratio | 7.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 45.76 |
| P/OCF Ratio | 17.65 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 43.24 |
| EV / Sales | 5.81 |
| EV / EBITDA | 12.26 |
| EV / EBIT | 15.74 |
| EV / FCF | 62.71 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.80 |
| Quick Ratio | 2.40 |
| Debt / Equity | 3.41 |
| Debt / EBITDA | 3.85 |
| Debt / FCF | 20.12 |
| Interest Coverage | 3.13 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 27.78% |
| Return on Assets (ROA) | 8.60% |
| Return on Invested Capital (ROIC) | 10.78% |
| Return on Capital Employed (ROCE) | 14.60% |
| Weighted Average Cost of Capital (WACC) | 11.23% |
| Revenue Per Employee | $405,391 |
| Profits Per Employee | $54,492 |
| Employee Count | 3,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 8.63 |
Taxes
| Measure | Value |
|---|
| Income Tax | 100.62M |
| Effective Tax Rate | 38.10% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.86 |
| 52-Week Price Change | +8.43% |
| 50-Day Moving Average | 18.49 |
| 200-Day Moving Average | 17.00 |
| Relative Strength Index (RSI) | 45.60 |
| Average Volume (20 Days) | 2,035,540 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 16.09M |
| Short Previous Month | 14.75M |
| Short % of Shares Out | 5.64% |
| Short % of Float | 8.01% |
| Short Ratio (days to cover) | 7.82 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.22B |
| Gross Profit | 668.51M |
| Operating Income | 448.99M |
| Pretax Income | 264.10M |
| Net Income | 163.48M |
| EBITDA | 576.58M |
| EBIT | 448.99M |
| Earnings Per Share (EPS) | $0.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 356.95M |
| Total Debt | 2.27B |
| Net Cash | -1.91B |
| Net Cash Per Share | -$6.70 |
| Equity (Book Value) | 665.65M |
| Book Value Per Share | 2.33 |
| Working Capital | 415.22M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 292.19M |
| Capital Expenditures | -179.49M |
| Depreciation & Amortization | 127.59M |
| Net Borrowing | -82.12M |
| Free Cash Flow | 112.70M |
| FCF Per Share | $0.39 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.97% |
| Operating Margin | 36.92% |
| Pretax Margin | 21.72% |
| Profit Margin | 13.44% |
| EBITDA Margin | 47.41% |
| EBIT Margin | 36.92% |
| FCF Margin | 9.27% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.36% |
| Shareholder Yield | -1.36% |
| Earnings Yield | 3.16% |
| FCF Yield | 2.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $22.61 |
| Price Target Difference | 25.82% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 6.31% |
| EPS Growth Forecast (3Y) | 11.20% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.79 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |